131 related articles for article (PubMed ID: 7308991)
21. Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis B.
Loriot MA; Marcellin P; Bismuth E; Martinot-Peignoux M; Boyer N; Degott C; Erlinger S; Benhamou JP
Hepatology; 1992 Jan; 15(1):32-6. PubMed ID: 1727796
[TBL] [Abstract][Full Text] [Related]
22. Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).
Weller IV; Bassendine MF; Craxi A; Fowler MJ; Monjardino J; Thomas HC; Sherlock S
Gut; 1982 Sep; 23(9):717-23. PubMed ID: 6179819
[TBL] [Abstract][Full Text] [Related]
23. Quantitative correlation between the Dane particle-associated DNA polymerase and the hepatitis B e antigen.
Siegert W; Grunst J; Wilmanns W; Frösner GG; Deinhardt F
Infection; 1979; 7(5):220-2. PubMed ID: 511339
[TBL] [Abstract][Full Text] [Related]
24. Relationship between HBV-specific DNA polymerase and HBe antigen/antibody system in chronic HBV infection: factors determining selection of patients and outcome of antiviral therapy.
Craxi A; Weller IV; Bassendine MF; Fowler MJ; Monjardino J; Thomas HC; Sherlock S
Gut; 1983 Feb; 24(2):143-7. PubMed ID: 6852624
[TBL] [Abstract][Full Text] [Related]
25. Improvement of hepatitis B-associated glomerulonephritis after antiviral combination therapy.
de Man RA; Schalm SW; van der Heijden AJ; ten Kate FW; Wolff ED; Heijtink RA
J Hepatol; 1989 May; 8(3):367-72. PubMed ID: 2471723
[TBL] [Abstract][Full Text] [Related]
26. Dane particles and associated DNA-polymerase activity in saliva of chronic hepatitis B carriers.
Macaya G; Visoná KA; Villarejos VM
J Med Virol; 1979; 4(4):291-301. PubMed ID: 541682
[TBL] [Abstract][Full Text] [Related]
27. Presence of HBeAg, DNA polymerase activity, Dane particle in different categories of HBsAg carriers and evidence of hepatitis type B infection in their family contacts.
Zanetti AR; Ferroni P
Boll Ist Sieroter Milan; 1977 Mar; 56(1):79-86. PubMed ID: 861076
[No Abstract] [Full Text] [Related]
28. Spontaneous disappearance of viral replication and liver cell inflammation in HBsAg-positive chronic active hepatitis: results of a placebo vs. interferon trial.
Schalm SW; Heijtink RA
Hepatology; 1982; 2(6):791-4. PubMed ID: 7141389
[TBL] [Abstract][Full Text] [Related]
29. Infectivity markers in HBsAg chronic carriers and intrafamilial spread of hepatitis B virus infection.
Pastore G; Dentico P; Angarano G; Lapedota E; Schiraldi O
Hepatogastroenterology; 1981 Feb; 28(1):20-2. PubMed ID: 7216135
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of hepatitis B X antigen, antibodies to X antigen, and antibodies to the viral polymerase during hepatitis B virus infection.
Horiike N; Blumberg BS; Feitelson MA
J Infect Dis; 1991 Dec; 164(6):1104-12. PubMed ID: 1955710
[TBL] [Abstract][Full Text] [Related]
31. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
Perrillo R; Campbell C; Wellinghoff W; Gelb L
Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131
[TBL] [Abstract][Full Text] [Related]
32. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
[TBL] [Abstract][Full Text] [Related]
33. Histological and immunohistochemical study of hepatitis B virus in human immunodeficiency virus infection.
Goldin RD; Fish DE; Hay A; Waters JA; McGarvey MJ; Main J; Thomas HC
J Clin Pathol; 1990 Mar; 43(3):203-5. PubMed ID: 2332517
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B pre-S1 and pre-S2 proteins: clinical significance and relation to hepatitis B virus DNA.
van Ditzhuijsen TJ; Kuijpers LP; Koens MJ; Rijntjes PJ; van Loon AM; Yap SH
J Med Virol; 1990 Oct; 32(2):87-91. PubMed ID: 2280257
[TBL] [Abstract][Full Text] [Related]
35. Tests for Dane particles in serum concentrates of HBsAg positive hemodialysis patients.
Hess G; Arnold W; Koesters W; Meyer zum Büschenfelde KH
Clin Nephrol; 1979 Jan; 11(1):18-22. PubMed ID: 428150
[TBL] [Abstract][Full Text] [Related]
36. Incidence of hepatitis B virus DNA and DNA-polymerase in sera of Italian asymptomatic carriers with the serological markers of HBV.
Carloni G; Delfini C; Colloca S; Alfani E; Taliani G; De Bac C
Arch Virol; 1986; 87(1-2):97-105. PubMed ID: 3942507
[TBL] [Abstract][Full Text] [Related]
37. Long-term follow-up of chronic hepatitis patients with HBsAg, HBeAg and Dane particles associated DNA polymerase in serum.
Norkrans G; Nordenfelt E; Hermodsson S; Iwarson S
Scand J Infect Dis; 1980; 12(2):159-60. PubMed ID: 7375828
[TBL] [Abstract][Full Text] [Related]
38. [e/Anti-e system in liver disease].
Resta ML; Freni MA; Berlinghieri G; Ajello A; Crinò M; Ferraù O
Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2123-8. PubMed ID: 7459125
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B disease in dialysis and transplant patients. Further epidemiologic and serologic studies.
Harnett JD; Zeldis JB; Parfrey PS; Kennedy M; Sircar R; Steinmann TI; Guttmann RD
Transplantation; 1987 Sep; 44(3):369-76. PubMed ID: 2820093
[TBL] [Abstract][Full Text] [Related]
40. Radioimmunoassay in the detection of the hepatitis B e antigen/antibody system in asymptomatic carriers of hepatitis B surface antigen. Correlation with serum Dane particle associated DNA polymerase activity.
Pastore G; Zanetti AR; Ferroni P; Dentico P; Angarano G; Schiraldi O
Infection; 1979; 7(6):279-82. PubMed ID: 546799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
